Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:28:43.783Z.
Calculation as of: 2026-10-06T18:28:43.783Z.
Quote observation: 2026-10-06T18:25:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97452f2638ad5d60f1716ef7360feea6a822b872a50cf44a9ba771f9e60b5836
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Twist Bioscience Corporation
Market Cap
$10.72B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.69B
EV/EBIT Ratio
7.68x
TTM Avg
8.63x
3Y Avg
11.13x
5Y Avg
11.58x
Market Cap
$10.87B
EV/EBIT Ratio
51.95x
TTM Avg
25.50x
3Y Avg
52.86x
5Y Avg
123.66x
Market Cap
$10.97B
EV/EBIT Ratio
24.52x
TTM Avg
26.33x
3Y Avg
30.62x
5Y Avg
34.46x
Market Cap
$10.35B
EV/EBIT Ratio
15.26x
TTM Avg
24.55x
3Y Avg
55.38x
5Y Avg
46.15x
Market Cap
$10.14B
EV/EBIT Ratio
16.60x
TTM Avg
19.50x
3Y Avg
23.74x
5Y Avg
27.91x
Market Cap
$10.13B
EV/EBIT Ratio
30.73x
TTM Avg
14.47x
3Y Avg
11.64x
5Y Avg
12.65x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.72B | N/A | N/A | N/A | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.69B | 7.68x | 8.63x | 11.13x | 11.58x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 51.95x | 25.50x | 52.86x | 123.66x |
| 10x Genomics, Inc. (TXG)vs › | $10.54B | N/A | N/A | N/A | N/A |
| The Cooper Companies, Inc. (COO)vs › | $10.97B | 24.52x | 26.33x | 30.62x | 34.46x |
| Globus Medical, Inc. (GMED)vs › | $10.35B | 15.26x | 24.55x | 55.38x | 46.15x |
| ImmunityBio, Inc. (IBRX)vs › | $10.35B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 16.60x | 19.50x | 23.74x | 27.91x |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | 30.73x | 14.47x | 11.64x | 12.65x |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 45.13x | 74.68x | 59.09x | 57.11x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
